SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-000683
Filing Date
2019-01-04
Accepted
2019-01-04 07:13:53
Documents
3
Period of Report
2019-01-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-1236_18k.htm 8-K 39656
2 EX-99.1 a19-1236_1ex99d1.htm EX-99.1 20365
3 GRAPHIC g12361mmi001.jpg GRAPHIC 3622
  Complete submission text file 0001104659-19-000683.txt   66422
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 19508390
SIC: 2834 Pharmaceutical Preparations